| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/31/2004 | EP0793668B1 Derivatives of carbohydrates and compositions containing them |
| 03/31/2004 | EP0788358B1 Use of pyrazole compounds for the treatment of glomerulonephritis, cancer, atherosclerosis or restenosis |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0781766B1 Heterocyclic derivative and medicine |
| 03/31/2004 | EP0777484B1 Intravenous alendronate formulations |
| 03/31/2004 | EP0770065B1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
| 03/31/2004 | EP0755249B1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
| 03/31/2004 | CN1486321A Indole derivative and its medicine application |
| 03/31/2004 | CN1486320A Inhibitors of cruzipain and other cysteine proteases |
| 03/31/2004 | CN1486314A Aminotriazolopyridiine derivatives as adenosine receptor ligands |
| 03/31/2004 | CN1486313A Compounds for use in the treatment of skin conditions |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 03/31/2004 | CN1486308A Piperazinylcarbonylquinolines and -isoquinolines |
| 03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 03/31/2004 | CN1486301A 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 03/31/2004 | CN1486300A 1,4-disubstituted piperazine derivatives useful as uro-selective dollar g(a)1-adrenoceptor blockers |
| 03/31/2004 | CN1486298A Prodrugs of excitatory amino acids |
| 03/31/2004 | CN1486204A Compositions for inducing islet neogenesis, containing gastrin/CCK receptor ligands and egf receptor ligands |
| 03/31/2004 | CN1486193A Effective antitumour treatments |
| 03/31/2004 | CN1486191A Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 03/31/2004 | CN1486190A Compositions containing an active fraction isolated from scutellariae barbatae and methods of use |
| 03/31/2004 | CN1486181A Lipid peroxide-lowering compositions |
| 03/31/2004 | CN1486180A Methods for treating neuropsychiatric disorders with NMDA receptor antagonists |
| 03/31/2004 | CN1486179A Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 03/31/2004 | CN1485090A Novel fibrin sealer and the application thereof |
| 03/31/2004 | CN1485088A Cinese material medical preparation for curing children' hyperkinetic symptom and the preparation process thereof |
| 03/31/2004 | CN1485071A Medicine for curing hydrocephalus, brain abscess and brain tumor and preparation process thereof |
| 03/31/2004 | CN1485052A aqualene composition with anti-fatigue and delaying ageing function |
| 03/31/2004 | CN1485045A Medication composition dispelling wind, facilitating ATP synthesis, building up immune competency |
| 03/31/2004 | CN1485026A Intravenous injection liquid preparing method of oxygen-enriched broad transfusion |
| 03/31/2004 | CN1143858C 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 03/31/2004 | CN1143857C Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 03/31/2004 | CN1143855C I (ortho)-anthranilamide derivatives as anti-coagulants |
| 03/31/2004 | CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same |
| 03/31/2004 | CN1143851C Penicillene compounds and derivatives therefrom |
| 03/31/2004 | CN1143848C 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists |
| 03/31/2004 | CN1143847C Thio-oxindole derivatives |
| 03/31/2004 | CN1143680C Method of enhancing bioavailability of fexofenadine and its derivatives |
| 03/31/2004 | CN1143672C Pharmaceutical compositions comprising uridine triphosphate |
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713633 Compounds capable of cleaving double-stranded DNA and method of utilization of the same |
| 03/30/2004 | US6713623 Useful as intermediates in the synthesis of biologically active compounds |
| 03/30/2004 | US6713621 Chimeric compositions having multi-modalities are also provided which can affect a plurality of gene functions by interfering with splicing or translation as well as transcription |
| 03/30/2004 | US6713616 Detecting binding |
| 03/30/2004 | US6713510 Amide and ester derivatives |
| 03/30/2004 | US6713505 Such as n-(2-((3-(aminooxoacetyl)-2-ethylbenzo(b)thiophen-4-yl)oxy) acetyl)glycine; secretory phospholipase a2 (spla2) |
| 03/30/2004 | US6713499 Adenosine receptor agonist |
| 03/30/2004 | US6713497 Reducing side effects from excess gamma amino butyric acid (gaba) in central nervous system |
| 03/30/2004 | US6713489 Treatment of atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, pancreatitis, myocardial infarction, stroke, restenosis, or syndrome x |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713485 Antiproliferative agents; side effect reduction |
| 03/30/2004 | US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 03/30/2004 | US6713482 Such as (e)-1-(2-pyridyl)-2-styryl-1h-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 03/30/2004 | US6713478 Cyclocarbamate derivatives as progesterone receptor modulators |
| 03/30/2004 | US6713476 Substituted cycloalkyls as inhibitors of a beta protein production |
| 03/30/2004 | US6713473 6-carbamate-1,2,3,4-tetrahydrocarbazole derivatives; affinity for neuropeptide y receptors |
| 03/30/2004 | US6713472 Thiazine or pyrazine derivatives |
| 03/30/2004 | US6713464 Derivatives of 3,3-diphenylpropylamines |
| 03/30/2004 | US6713463 Methods and compositions for treating and preventing mucositis |
| 03/30/2004 | US6713461 Eletriptan and sulphobutylether-beta-cyclodextrin; well tolerated intranasal delivery; bioavailability; fast acting |
| 03/30/2004 | US6713454 Prodrugs of etoposide and etoposide analogs |
| 03/30/2004 | US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life |
| 03/30/2004 | US6713291 Method of immunotherapy; obtain electrodes, obtain waveform generator, generate electrically conductive pathways between electrodes and generator, incubate with transfer particles, transfer particles into cells with electrical pulse |
| 03/30/2004 | US6713246 Method of producing interleukin-1 receptor antagonist in a syringe filled with blood |
| 03/30/2004 | US6713093 Antialopecia agent |
| 03/30/2004 | US6713091 With licorice; beverage for curing a hangover, source of dietary fiber |
| 03/30/2004 | US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength |
| 03/30/2004 | US6713074 Cosmetic composition and method |
| 03/30/2004 | US6713065 Methods of using hedgehog proteins to modulate hematopoiesis and vascular growth |
| 03/30/2004 | US6713048 Δ9 tetrahydrocannabinol (Δ9 THC) solution metered dose inhalers and methods of use |
| 03/30/2004 | CA2339073C Composition for suppressing cellular fibrousing and method for preparing an extract from loquat seeds |
| 03/30/2004 | CA2291222C Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| 03/30/2004 | CA2278687C 5-aroylnaphthalene derivatives |
| 03/30/2004 | CA2262637C Use of hyaluronidase |
| 03/30/2004 | CA2239245C N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same |
| 03/30/2004 | CA2217499C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/30/2004 | CA2091058C Methylen-oxindole derivatives and process for their preparation |
| 03/30/2004 | CA2079706C Inhibitor of atherosclerotic intimal thickening |
| 03/30/2004 | CA2067924C N-alkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
| 03/25/2004 | WO2004024921A1 Human antihuman mcp-1 antibody and antibody fragment thereof |
| 03/25/2004 | WO2004024911A1 Enhancers specific to motor nerve cells/sensory nerve cells |
| 03/25/2004 | WO2004024884A2 Syts as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | WO2004024883A2 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024882A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024880A2 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024879A2 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024754A1 Proline ester and preparation containing the same for percutaneous administration |
| 03/25/2004 | WO2004024721A1 Hydantoin derivatives und deren verwendung als tace inhibitoren |
| 03/25/2004 | WO2004024717A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 03/25/2004 | WO2004024715A1 Sulphonamide derivatives and their use as tace inhibitors |
| 03/25/2004 | WO2004024705A1 Five-membered heterocyclic compounds |
| 03/25/2004 | WO2004024694A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 03/25/2004 | WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 03/25/2004 | WO2004024685A1 Novel dipeptide compound and medical use tehreof |
| 03/25/2004 | WO2004024677A1 N-hydroxyformamidine derivative |